Emery P W, Edwards R H, Rennie M J, Souhami R L, Halliday D
Br Med J (Clin Res Ed). 1984 Sep 8;289(6445):584-6. doi: 10.1136/bmj.289.6445.584.
Rates of synthesis of protein were measured in vivo in skeletal muscle and in the whole body of cachectic patients with cancer and in normal healthy men, using a tracer infusion of leucine labelled with a stable isotope. Synthesis of protein in muscle was significantly reduced in the patients with cancer (0.030 v 0.198%/hour; p less than 0.01), whereas whole body rates of protein synthesis and degradation did not differ significantly between the two groups. Thus depression of synthesis of protein in muscle appeared to be the immediate cause of muscle wasting in cancerous cachexia. Any therapeutic intervention that aims at preventing the onset of cachexia should be designed to stimulate the synthesis of protein in muscle, and measurement of turnover of protein may be used to evaluate such treatment provided that rates of protein synthesis are measured directly in specific tissues.
采用稳定同位素标记的亮氨酸示踪输注法,在患有癌症的恶病质患者的骨骼肌和全身以及正常健康男性体内测量蛋白质合成速率。癌症患者肌肉中的蛋白质合成显著降低(0.030对0.198%/小时;p<0.01),而两组之间全身蛋白质合成和降解速率没有显著差异。因此,肌肉中蛋白质合成的抑制似乎是癌性恶病质中肌肉消耗的直接原因。任何旨在预防恶病质发作的治疗干预措施都应设计为刺激肌肉中蛋白质的合成,并且只要直接在特定组织中测量蛋白质合成速率,蛋白质周转的测量就可用于评估此类治疗。